©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 7, 2005; 11(21): 3245-3249
Published online Jun 7, 2005. doi: 10.3748/wjg.v11.i21.3245
Published online Jun 7, 2005. doi: 10.3748/wjg.v11.i21.3245
Table 2 Association of Ki67 expression with N-stage, Dukes and presence of hot spot areas in rectal cancer.
| Ki67 expression | P | ||
| ≤40 | >40 | ||
| n (%) | n (%) | ||
| N-stage | 0.020 | ||
| 0 | 50 (63) | 48 (73) | |
| 1 | 12 (15) | 14 (21) | |
| 2 | 18 (23) | 4 (6) | |
| Dukes | 0.012 | ||
| 1 | 9 (11) | 17 (26) | |
| 2 | 53 (66) | 32 (48) | |
| 3 | 10 (13) | 15 (23) | |
| 4 | 8 (10) | 2 (3) | |
| Hot spot | <0.001 | ||
| ≤50 | 65 (81) | 10 (15) | |
| >50 | 15 (19) | 56 (85) | |
- Citation: Salminen E, Palmu S, Vahlberg T, Roberts PJ, Söderström KO. Increased proliferation activity measured by immunoreactive Ki67 is associated with survival improvement in rectal/recto sigmoid cancer. World J Gastroenterol 2005; 11(21): 3245-3249
- URL: https://www.wjgnet.com/1007-9327/full/v11/i21/3245.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i21.3245